Residents with self-care disability less likely to receive cancer treatment
By
Alicia Lasek
Mar 05, 2021
Many nursing home residents do not receive cancer-directed treatment, and they are even less likely to do so if they have a self-care disability, according to a new study.
Treatment patterns, not genetics, drive prostate cancer disparities, study finds
By
Alicia Lasek
May 29, 2023
Prostate cancer, which affects 1 in 11 men aged 70 and older, has some of the largest disparities in outcomes across all cancer types, investigators say.
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Common measure of mortality also predicts cancer survival in seniors
By
Alicia Lasek (f3)
May 09, 2022
The Charlson Comorbidity Index accurately predicts morbidity in elderly patients with cancer, a new investigation has found.
Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
Functional limitations more than double over 20 years among U.S. cancer survivors
By
Alicia Lasek
Jun 08, 2023
More lives are being saved from cancer, but the findings underscore the need for greater access to high quality survivorship care, investigators say.
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.